ConductScience.org, home

Trial · NCT06812559

Progesterone Primed Ovarian Stimulation Versus GnRH Antagonist Protocols in Women With Polycystic Ovarian Syndrome

NCT06812559, Completed, El Shatby University Hospital for Obstetrics and Gynecology

3 sourcestrials-2026-11-12-0.5.0

Download JSON
Cite this record

ConductScience Library. Progesterone Primed Ovarian Stimulation Versus GnRH Antagonist Protocols in Women With Polycystic Ovarian Syndrome. Trials, record NCT06812559. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT06812559

On this page

Trial

As registered on ClinicalTrials.gov, in the graph's capture of the registry.

Title
Progesterone Primed Ovarian Stimulation Versus GnRH Antagonist Protocols in Women With Polycystic Ovarian Syndrome
NCT number
NCT06812559
Status
Completed
Enrollment
100 participants, actual
Lead sponsor
El Shatby University Hospital for Obstetrics and Gynecology
Conditions
Controlled Ovarian Hyperstimulation, Polycystic Ovarian Syndrome
Interventions
Progesterone, GnRH antagonist (Cetrorelix)
First posted
2025-02-06
Last updated
2025-02-25

Source ClinicalTrials.gov

Registered outcomes6

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

ListOutcomeTime frameDescription
PrimaryNumber of oocytes retrieved (ovarian response).BaselineTotal number of oocytes retrieved (in both groups)
PrimaryPercentage of MII oocytes.BaselineNumber of MII oocytes to the total number of oocytes retrieved (in both groups)
PrimaryRate of good-quality blastocysts available for cryopreservationBaselinepercentage of the number of good-quality blastocysts to the number of 2PN fertilized oocytes cultured
SecondaryFertilization rateBaselinePercentage of the number of MII oocytes microinjected which transform into 2PN
SecondaryRate of blastocyst formationBaselinepercentage of the number of blastocysts formed to the number of 2PN fertilized oocytes cultured
SecondaryClinical pregnancy rate after 1st FETBaselinedefined as elevated serum β-HCG (+) the presence of gestational sac(s) or fetal heartbeats (fetal pole) by ultrasonography

Outcomes0

Each outcome the trial posted results for, in ClinicalTrials.gov's words.

None in this release.

Results by group0

Each measurement the trial posted, group by group, in the words and numbers it posted.

None in this release.

Participant flow0

How many started, completed or left each group, period by period.

None in this release.

Adverse events0

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

None in this release.

Adverse event totals0

The totals the trial posted for each group.

None in this release.

Papers14

The papers the trial lists on ClinicalTrials.gov.

PMIDListed asSource
12498425BACKGROUNDPubMed
16672246BACKGROUNDPubMed
16798287BACKGROUNDPubMed
17169171BACKGROUNDPubMed
18308833BACKGROUNDPubMed
20008886BACKGROUNDPubMed
22500852BACKGROUNDPubMed
27126581BACKGROUNDPubMed
27428219BACKGROUNDPubMed
27509101BACKGROUNDPubMed

1 to 10 of 14

See all 14 papers

Grants0

The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.

None in this release.

Trial comparisons0

Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.

None in this release.

Tests0

The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.

None in this release.

Data dates

The day each source was copied for this release.

ClinicalTrials.gov
2026-11-12
ClinicalTrials.gov
Results, from AACT
2026-03-23
AACT
NIH grant links
2026-11-13
NIH RePORTER

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this trial from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/trials/v1/NCT06812559

GET https://conductscience.org/api/trials/v1/NCT06812559/registered